SEC Form D private-offering filing

Spinogenix, Inc.

Name: Spinogenix, Inc. - new SEC Form D private-offering filing, Los Angeles, CA
Published: 2026-03-09

A new SEC Form D private-offering notice from Los Angeles, CA, a $35,000,000 filer-stated offering target in Biotech. The source filing is one click away.

Spinogenix, Inc. site↗ Verified via SEC Form D

Clinical stage biopharmaceutical company developing oral small molecule drugs to regenerate brain synapses for ALS, schizophrenia, Alzheimer's, and Fragile X syndrome.

Filed 2026-03-09Filed to raise $35,000,000First money in 2025-11-21Raised so far $10,606,566HQ (as filed) Los Angeles, CASector Biotech ✓Stage (inferred) GrowthCall status Late filing

Source linked the Form D on EDGAR↗Website verified spinogenix.com↗Named in the filing 4 executives & directors

Open this row on the live feed →More new filings in California →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.